Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell

H-B Sun1, H-Y Zheng, X Yan

  • 1Department of Stomatology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. sunhuibinqd@126.com.

Abstract

Insights

Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma (OSCC) cells. Combining survivin knockdown with radiation therapy significantly boosts apoptosis and inhibits tumor growth in vitro and in vivo.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy Research

Background:

  • Survivin, an inhibitor of apoptosis protein, is overexpressed in cancers and confers resistance to radiation therapy.
  • Oral squamous cell carcinoma (OSCC) exhibits survivin overexpression, contributing to treatment resistance.

Purpose of the Study:

  • To investigate the effect of survivin knockdown using siRNA on apoptosis induction and radiosensitivity in OSCC cells.
  • To evaluate the combined efficacy of survivin silencing and radiotherapy in vitro and in vivo.

Main Methods:

  • Oral squamous cell carcinoma (OSCC) KB cell lines were treated with radiotherapy and/or survivin-targeting siRNA.
  • Cell viability, proliferation (colony-forming ability), and apoptosis were assessed using MTT assay and flow cytometry.
  • Tumor-bearing mice models were used to evaluate in vivo efficacy.

Main Results:

  • Survivin knockdown reduced cell proliferation and increased radiation-induced apoptosis in KB cells.
  • Apoptosis was augmented by survivin silencing, especially when combined with irradiation.
  • Colony formation was significantly inhibited by the combination of survivin silencing and irradiation.

Conclusions:

  • Survivin silencing sensitizes OSCC cells to radiotherapy, enhancing apoptosis and inhibiting proliferation and colony formation.
  • The combination of survivin silencing and radiation therapy demonstrates significant therapeutic potential in both in vitro and in vivo models of OSCC.
  • Survivin silencing potentiates the anti-tumor effects of irradiation, offering a promising strategy for improving OSCC treatment outcomes.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K